Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Clinigen Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Clinigen Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 18 Feb 2021 | Lorem |
| Avanir to launch Phase III European/Japanese trials of AVP-786 in agitation/aggression in Alzheimer's disease this year – CEO | 31 Mar 2017 | Hamish McDougall |
| Market for service providers sourcing biosimilar reference products expected to grow - experts | 01 Dec 2014 | , |
| Neovii seeks late-stage immunology, haematology assets for growth, mulls US partner for Phase III GvHD drug - exec | 28 Nov 2014 | Jinan Harb |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer